Quinolone resistance and correlation to other antimicrobial resistances in faecal isolates of Escherichia coli in Hong Kong

Chemotherapy

Volumn 54, Issue 4, 2008, Pages 274-278

  Chu, Yiu Wai ^a,b   Cheung, Terence K M ^a   Wong, Chi Ho ^a   Tsang, Grand K L ^a   Lee, Kenwai ^a   Lau, Stephen S Y ^a   Kam, Kai Man ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b Microbiology Division   (Hong Kong)

Author keywords

Lactams; Aminoglycosides; CTX M; Fluoroquinolones

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHAMYCIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NETILMICIN; NITROFURAN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE TRANSFER; HONG KONG; INTESTINE FLORA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QNRA GENE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HONG KONG; HUMANS; QUINOLONES;

EID: 48049115332     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149718     Document Type: Article

References (13)

1. Ling TK, Liu EY, Cheng AF: A 13-year study of antimicrobial susceptibility of common gram-negative bacteria isolated from the bloodstream in a teaching hospital. Chemotherapy 2001;47:29-38.
2. Kam KM, Kam SSY, Cheung DTL, Tung VWN, Au WF, Cheung MM: Molecular characterization of quinolone-resistant Neisseria gonorrhoeae in Hong Kong. Antimicrob Agents Chemother 2003;47:436-439.
3. Chu YW, Chu MY, Luey KY, Ngan YW, Tsang KL, Kam KM: Genetic relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in Hong Kong. J Clin Microbiol 2004;42:3321-3323.
4. Lee CC, Lee VW, Chan FK, Ling TK: Levofloxacin-resistant Helicobacter pylori in Hong Kong. Chemotherapy 2008;54:50-53.
5. Cheung TKM, Chu MY, Ma CH, Yung RWH, Kam KM: Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J Antimicrob Chemother 2005;56:586-589.
6. Qin X, Razia Y, Johnson JR, Stapp JR, Boster DR, Tsosie T, Smith DL, Braden C, Gay K, Angulo FJ, Tarr PI: Ciprofloxacin-resistant gram-negative bacilli in the faecal microflora of children. Antimicrob Agents Chemother 2006;50:3325-3329.
7. CLSI: Performance Standards for Antimicrobial Susceptibility Testing. Supplement M100-S13. Wayne, Clinical and Laboratory Standard Institute, 2003.
8. Hooper DC: Mechanisms of quinolone resistance. Drug Resist Updates 1999;2:38-55.
9. Philippon A, Arlet G, Jacoby GA: Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002;46:1-11.
10. Kadima TA, Weiner JH: Mechanism of suppression of piperacillin resistance in Enterobacteria by tazobactam. Antimicrob Agents Chemother 1997;41:2177-2183.
11. Leverstein-van Hall MA, Blok HEM, Donders ART, Paauw A, Fluit AC, Verhoef J: Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 2003;187:251-259.
12. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO: Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001;33:1288-1294.
13. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF: Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 2003;36:183-187.